Disclosure Of Cash Flow Statement [Text Block]

BioInvent International - Filing #678852

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-01-01
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-01-01
Disclosure of cash flow statement [text block]
Förfallostruktur finansiella skulder – odiskonterade kassaflöden  
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
259 548 SEK
515 047 SEK
515 047 SEK
910 755 SEK
Income taxes paid (refund) [abstract]
Income taxes paid (refund), classified as operating activities
90,000 SEK
SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.